prognostic factors. Haematologica, 95 (11), 1952–1959. doi:10.3324/ haematol.2010.026989 Gore, L., Chawla, S., Petrilli, A., Hemenway, M., Schissel, D., Chua, V., . . . Oxenius, B. (2009). Aprepitant in adolescent patients for prevention of chemotherapy-induced nausea and vomiting: a randomized, double-blind, placebo-controlled study of efficacy and tolerability. Pediatric Blood and Cancer, 52 (2), 242-247. doi:10.1002/pbc.21811 Graham, K. e Unger, E. (2018). Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment. International Journal of Nanomedicine, 4 (13), 6049–6058. doi:10.2147/IJN.S140462 Gray, R. N. (2010). Scuba diving post-bleomycin therapy: A case report. Undersea and Hyperbaric Medicine, 37 (6), 455–457. Gray, R. N. (2014). More on scuba diving and bleomycin. Undersea and Hyperbaric Medicine, 41 (6), 605. Habetz, K., Ramakrishnaiah, R., Raina, S. K., Fitzgerald, R. T. e Hinduja, A. (2016). Posterior reversible encephalopathy syndrome: A comparative study of pediatric versus adult patients. Pediatric Neurology, 65, 45–51. doi:10.1016/j.pediatrrneurol.2016.09.001 Hashemi, A., Bahrololoumi, Z., Khaksar, Y., Saffarzadeh, N., Neamatzade, H. e Foroughi, E. (2015). Mouth-rinses for the prevention of chemotherapy induced oral mucositis in children: A systematic review. Iranian Journal of Pediatric Hematology and Oncology, 5 (2), 106–112. Hawley, P., Hovan, A., McGahan, C. E. e Saunders, D. (2014). A randomized placebo-controlled trial of manuka honey for radiation-induced oral mucositis. Supportive Care in Cancer, 22 (3), 751-761. doi:10.1007/s00520-013-2031-0 Henry, W. L., Gardin, J. M. e Ware, J. H. (1980). Echocardiographic
and adolescents with cancer and blood disorders (4 a ed., pp. 565– 571). Glenview, IL: Association of Pediatric Hematology/Oncology Nurses. Howard, S. C., Jones, D. P. e Pui, C. H. (2011). The tumor lysis syndrome. New England Journal of Medicine, 364 (19), 1844–1854. doi:10.1056/ NEJMra0904569 Howard, S. C., Trifilio, S., Gregory, T. K., Baxter, N. e McBride, A. (2016). Tumor lysis syndrome in the era of novel and targeted agents in patients with hematologic malignancies: A systematic review. Annals of Hematology, 95 (4), 563–573. doi:10.1007/s00277-015-2585-7 Huillard, O., Bakalian, S., Levy, C., Desjardins, L., Lumbroso-LeRouic, L., Pop, S., . . . Le Tourneau, C. (2014). Ocular adverse events of molecularly targeted agents approved in solid tumours: A systematic review. European Journal of Cancer, 50 (3), 638–648. doi:10.1016/j. ejca.2013.10.016 Janelsins, M. C., Tejani, M., Kamen, C., Peoples, A. R., Mustian, K. M. e Morrow, G. R. (2013). Current pharmacotherapy for chemotherapy- induced nausea and vomiting in cancer patients. Expert Opinion on Pharmacotherapy, 14 (6), 757–766. doi:10.1517/14656566.2013.776541 Joerger, M. (2012). Prevention and handling of acute allergic and infusion reactions in oncology. Annals of Oncology, 23 (suppl 10), x313–x319. doi:10.1093/annonc/mds314 Johnson, J. D. e Theurer, W. M. (2014). A stepwise approach to the interpretation of pulmonary function tests. American Family Physician, 89 (5), 359–366. Johnston, D., Schurtz, E., Tourville, E., Jones, T., Boemer, A. e Giel, D. (2016). Risk factors associated with severity and outcomes in pediatric patients with hemorrhagic cystitis. Journal of Urology, 195 (4 Pt 2), 1312–1317. doi:10.1016/j.juro.2015.11.035 Jones, G. L., Will, A., Jackson, G. H., Webb, N. J., Rule, S. e British Committee for Standards in Haematology. (2015). Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology. British Journal of Hematology, 169 (5), 661–671. doi:10.1111/bjh.13403 Jones, R. J., Lee, K. S., Beschorner, W. E., Vogel, V. G., Grochow, L. B., Braine, H. G., . . . Saral, R. (1987). Veno-occlusive disease of the liver following bone marrow transplantation. Transplantation, 44 (6), 778–783. Jordan, K., Gralla, R., Jahn, F. e Molassiotis, A. (2014). International antiemetic guidelines on chemotherapy induced nausea and vomiting (CINV): Content and implementation in daily routine practice. European Journal of Pharmacology, 5, 197–202. doi:10.1016/j. ejphar.2013.09.073 Jordan, K., Jahn, F. e Aapro, M. (2015). Recent developments in the prevention of chemotherapy-induced nausea and vomiting (CINV): A comprehensive review. Annals of Oncology, 26 (6), 1081–1090. doi:10.1093/annonc/mdv138 Josephson, M. B. e Goldfarb, S. B. (2014). Pulmonary complications of childhood cancers. Expert Review of Respiratory Medicine, 8 (5), 561– 571. doi:10.1586/17476348.2014.923311 Kaufman, R. M., Djulbegovic, B., Gernsheimer, T., Kleinman, S., Tinmouth, A. T., Capocelli, K. E., . . . Tobian, A. A. (2015). Platelet transfusion: A clinical practice guideline from the AABB. Annals of Internal Medicine, 162 (3), 205–213. doi:10.7326/M14-1589 Kelesidis, T., Daikos, G., Boumpas, G. e Tsiodras, S. (2011). Does rituximab increase the incidence of infectious complications? A narrative review. International Journal of Infectious Diseases, 15 (1), e2–e16. doi:10.1016/j.ijid.2010.03.025 Kelvin, J. F. (2016). Fertility preservation before cancer treatment: Options, strategies, and resources. Clinical Journal of Oncology Nursing, 20 (1), 44-51. doi:10.1188/16.CJON.44-51 Kesik, V., Atas, E., Korkmazer, N. e Babacan, O. (2015). Clofarabine associated capillary leak syndrome in a child with lymphoma successfully treated with intravenous immunoglobulin.
measurements in normal subjects from infancy to old age. Circulation, 62 (5), 1054–1061. doi:10.1161/01.CIR.62.5.1054
Hensley, M. L., Hagerty, K. L., Kewalramani, T., Green, D. M., Meropol, N. J., Wasserman, T. H., … Schuchter, L. M. (2009). American Society of Clinical Oncology 2008 clinical practice guideline update: Use of chemotherapy and radiation therapy protectants. Journal of Clinical Oncology, 27 (1), 127–145. doi:10.1200/JCO.2008.17.2627 Hershman, D. L., Lacchetti, C., Dworkin, R. H., Lavoie Smith, E. M., Bleeker, J., Cavaletti, G., . . . American Society of Clinical Oncology. (2014). Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. Journal of Clinical Oncology, 32 (18), 1941–1967. doi:10.1200/JCO.2013.54.0914 Hesketh, P. J., Kris, M. G., Basch, E., Bohlke, K., Barbour, S. Y., Clark- Snow, R. A., . . . Lyman, G. H. (2017). Antiemetics: American Society of Clinical Oncology clinical practice guideline update . Journal of Clinical Oncology, 35 (28), 3240-3261. doi:10.1200/JCO.2017.74.4789 Hinduja, A., Habetz, K., Raina, S. K., Fitzgerald, R. T. e Sahaya, K. (2016). Predictors of seizures in patients with posterior reversible encephalopathy syndrome. Epilepsy and Behavior, 61, 97–101. doi:10.1016/j.yebeh.2016.05.001 Hockenberry, M. J., Hinds, P. S., Barrera, P., Bryant, R., Adams- McNeill, J., Hooke, C., . . . Manteuffel, B. (2003). Three instruments to assess fatigue in children with cancer: The child, parent and staff perspectives. Journal of Pain and Symptom Management, 25 (4), 319– 328. doi:10.1016/S0885-3924(02)00680-2 Hoffman, R., Benz, E., Silberstein, L., Heslop, H., Weitz, J. e Anastasi, J. (2013). Pediatric transfusion medicine. Em C. Josephson e S. R. Sloan (Eds.), Hematology, basic principles and practice (pp. 1765–1766). Nova York, NY: Elsevier. Hogan, R. (2009). Implementation of an oral protocol and its effects on oral mucositis. Journal of Oncology Nursing, 26 (3), 125–135. doi:10.1077/1043454209334356 Hooke, M. C., Baggott, C., Robinson, D., Woolery, M., Maloney, A. M., Dulczak, S. e Madsen, L. (2011). Management of disease and treatment-related complications in pediatric oncology. Em C. Baggott, D. Fochtman, G. V. Foley e K. P. Kelly (Eds.), Nursing care of children
282 Plano de Estudos de Quimioterapia e Bioterapia Pediátrica: Quarta Edição
Powered by FlippingBook